HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The relationship between the intraoperative hypothermia and the residual neuromuscular of single intubation dose of vecuronium].

AbstractOBJECTIVE:
To study the relationship between the intraoperative hypothermia and the residual neuromuscular of single intubation dose of vecuronium.
METHODS:
The designed patients were from July to December in 2009. There are 36 male and 44 female cases. Their age was 19 to 59 years. The induction and sustaining are routine method. There were no additional muscle relaxant. Intraoperative nasopharyngeal temperature (T) < 36°C for the intraoperative hypothermia (LBT group) or non-intraoperative hypothermia group (NBT group). The patients turn back the PACU with tracheal intubation. Measured TOFr immediately after extubation.
RESULTS:
The incidence of residual neuromuscular single intubation dose of vecuronium was 28.7%. The incidence of postoperative residual neuromuscular was 43.2% (16/37) in the LBT group. The incidence of postoperative residual neuromuscular was 16.3% (7/43) in the NBT group. LBT group compared with the NBT group the incidence of postoperative residual neuromuscular was significant differences (P < 0.05).
CONCLUSION:
The incidence of residual neuromuscular increases. When patients in the surgery exist low body temperature.
AuthorsJian Li, Wei-dong Ye
JournalZhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi) Vol. 91 Issue 43 Pg. 3074-6 (Nov 22 2011) ISSN: 0376-2491 [Print] China
PMID22333063 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Vecuronium Bromide
Topics
  • Adult
  • Female
  • Humans
  • Hypothermia (etiology)
  • Intraoperative Complications
  • Male
  • Middle Aged
  • Muscle Relaxation (drug effects)
  • Vecuronium Bromide (administration & dosage, pharmacology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: